Although, not specific to the liver, these genome-wide association study (GWAS) data do support the hypothesis that GABA transporters encoded by SLC6A12 and SLC6A13 act to prevent the development of T2D. This evidence concerns the gene SLC6A12 and type 2 diabetes mellitus.